Australia markets closed

WELL Health Technologies Corp. (W7V.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.4270-0.0640 (-2.57%)
At close: 08:16AM CEST
Full screen
Previous close2.4910
Bid2.4970 x 0
Ask2.5440 x 0
Day's range2.4270 - 2.4270
52-week range2.3170 - 3.8200
Avg. volume516
Market cap617.337M
Beta (5Y monthly)1.24
PE ratio (TTM)30.34
EPS (TTM)0.0800
Earnings date08 Aug 2024 - 12 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot

    HEAWELL AI’s Clinical Co-Pilot technology participated in recently published evidence showing the integration of a highly accurate machine model for Chronic Kidney Disease (“CKD”) progression when paired with Electronic Health Record (“EHR”) linked clinical decision support, improves guideline-recommended testing in patients with CKD.HEALWELL’s subsidiary Khure Health (“Khure”) co-authored an abstract that was published this month in the American Journal of Kidney Diseases, providing evidence of

  • GlobeNewswire

    HEALWELL AI Reports Q1-2024 Financial Results

    HEALWELL AI achieved quarterly revenue from continuing operations of $4.58 million in Q1-2024, 132% higher compared to $1.97 million generated in Q1-2023 and 139% higher than $1.92 million generated in Q4-2023.Since its relaunch in Q4-2023 and its acquisition of Intrahealth, an enterprise class EHR service provider on February 1, 2024, the Company’s annual revenue run rate has more than doubled to over $20 million with the largest component of revenues now coming from SaaS and services.Managemen

  • Simply Wall St.

    WELL Health Technologies First Quarter 2024 Earnings: Beats Expectations

    WELL Health Technologies ( TSE:WELL ) First Quarter 2024 Results Key Financial Results Revenue: CA$231.6m (up 37% from...